TickerFacts.

MaxCyte, Inc. (MXCT): Gross Profit

Annual figures by period end, from SEC filings.

$26.80M
Year ended 2025-12-31
$24.60M
Trailing 12 months to 2026-06-30
-11.9%
3-year compound annual growth
+2.8%
5-year compound annual growth
$39.16M2019-12-31: $19.12M2020-12-31: $23.40M2021-12-31: $30.25M2022-12-31: $39.16M2023-12-31: $36.55M2024-12-31: $31.53M2025-12-31: $26.80M$26.80M
2019-12-31 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$26.80M-15.0%2026-03-25, From 2025-01-01
2024-12-31$31.53M-13.7%2026-03-25, From 2024-01-01
2023-12-31$36.55M-6.7%2025-03-11, From 2023-01-01
2022-12-31$39.16M+29.5%2024-03-12, From 2022-01-01
2021-12-31$30.25M+29.2%2023-03-15, From 2021-01-01
2020-12-31$23.40M+22.4%2022-03-22, From 2020-01-01
2019-12-31$19.12Mn/a2022-03-22, From 2019-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
MaxCyte, Inc. (MXCT)2025-12-31$26.80M-15.0%
iSpecimen Inc. (ISPC)2025-12-31$24.1K-99.4%
OneMedNet Corp (ONMD)2025-12-31-$503.0Kn/m
Cannabis Bioscience International Holdings, Inc. (CBIH)2025-05-31$262.9K+29.4%
Incyte Corp (INCY)2025-12-31$4.77B+21.4%
Icon PLC (ICLR)2024-12-31$2.34B+0.4%
Weed, Inc. (BUDZ)2025-12-31$0n/a
Vitaspring Biomedical Co. Ltd. (VSBC)2026-01-31$0n/a

Compare MXCT, ISPC, ONMD, CBIH side by side · Screen every company in Services-Commercial Physical & Biological Research ↗